Banner
Home
Search
Home News & Events Rituximab — a viable treatment option for ME/CFS?

Newsletter signup

Sign up for FREE e-newsletter!
Rituximab — a viable treatment option for ME/CFS? PDF Print E-mail
A recent Norwegian study generated a burst of media attention over the improvement reported by a small group of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients treated with a drug called rituximab, usually used for cancer and autoimmune disease. What is the significance of this study? Read more about it.
 
parkinDESIGN logo